Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy

Published:2013-10-08 Issue:7 Volume:134 Page:1695-1705
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Jaini Ritika¹,Rayman Patricia¹,Cohen Peter A.²,Finke James H.¹³,Tuohy Vincent K.¹³

Affiliation:

1. Department of Immunology; Lerner Research Institute, Cleveland Clinic; Cleveland OH

2. Division of Hematology/Oncology; Mayo Clinic in Arizona; Scottsdale AZ

3. Cleveland Clinic Lerner College of Medicine; Case Western Reserve University; Cleveland OH

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet derived growth factor receptor, in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2006

2. Sunitinib versus interferon alpha in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumor after imatinib failure;George;Eur J Cancer,2009

4. American Society of Clinical Oncology. Clinical cancer advances 2005: major research advances in cancer treatment, prevention and screening-a report from the American society of clinical oncology;Herbst;J Clin Oncol,2006

5. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells;Xin;Cancer Res,2009

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic and Local Strategies for Primary Prevention of Breast Cancer;Cancers;2024-01-05

2. Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy;Materials Today Bio;2022-12

3. Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling;OncoImmunology;2022-08-09

4. Calcium Channel Blockers Increase Sunitinib Effectiveness in Metastatic Renal Cell Carcinoma Treatment;Annals of Clinical and Analytical Medicine;2022

5. De-risking clinical trial failure through mechanistic simulation;Immunotherapy Advances;2022-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3